15 April, 2025

The CGT/ATMP Landscape & Challenges in Safety Data Collection

In this webinar, Tom Major discusses the intricate landscape of cell and gene therapies, including the market trends, types, and compliance considerations. Throughout the session, he delves into the therapeutic potentials and regulatory challenges these advanced therapies face, especially in oncology and rare diseases. Attendees will gain insights into the complexities of safety data collection and the future of regenerative medicine, making it a must-watch for anyone interested in the evolving field of medicinal products.

  • Cell and gene therapies have the potential to revolutionize the way we think about medicine, especially in treating rare and genetic diseases.
  • The cell and gene therapy market is expected to grow at a CAGR of 52% over the next five years, with oncology commanding 44% of the market by 2029.
  • Compliance and safety in cell and gene therapy require addressing challenges such as high regulatory scrutiny, long-term follow-up studies, and data management complexities.










    Discover how we can help you

    Close Popup

    This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

    Close Popup
    Privacy Settings saved!
    Privacy Settings

    When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

    These cookies are necessary for the website to function and cannot be switched off in our systems.

    Technical Cookies
    In order to use this website we use the following technically required cookies
    • wordpress_test_cookie
    • wordpress_logged_in_
    • wordpress_sec

    Cloudflare
    In order to use this website we use the following technically required cookies
    • __cfduid

    Decline all Services
    Save
    Accept all Services